SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

AISAP raises $13 Million in Seed for its AI ultrasound solution

Sam Altman-backed Apex emerges from stealth with $7M to help secure AI adoption

Gigi Levy-Weiss: "Creating jobs is no longer enough to fulfill one’s Zionist duty; we must change the country"

Full list of Israeli high-tech funding rounds in 2024

Buzz

Most popular

Daily

Weekly

1

Wiz deal to acquire Lacework collapses

2

Nvidia to acquire AI startup Deci for $300 million

3

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

4

Sam Altman-backed Apex emerges from stealth with $7M to help secure AI adoption

5

Permira acquiring control of BioCatch at $1.3 billion valuation

Epitomee

3 stories about Epitomee

גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki

The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level

גלולה של חברת אפיטומי epitomee

Weight loss pill success sparks stock surge at Epitomee Medical

04.09.23|Adiel Eithan Mustaki

The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway

Weight-Loss Pill Developer Epitomee Raises $8 Million

Epitomee develops an orally administered capsule that affects the stomach through mechanosensory stimulation, encouraging prolonged gastric emptying and giving patients the sensation of being full